Treatment of thymoma: A comparative study between Thailand and the United States and a review of the literature

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 3, 2004, Pages 236-246

  Sunpaweravong, Patrapim ^a,b   Kelly, Karen ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chemotherapy; Radiotherapy; Surgery; Thymoma; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LOMUSTINE; PACLITAXEL; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DYSPNEA; FEMALE; HUMAN; MALE; MEDLINE; MYASTHENIA GRAVIS; REVIEW; SYSTEMATIC REVIEW; THAILAND; THORAX PAIN; THYMECTOMY; THYMOMA; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; THAILAND; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

EID: 2942588393     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000092561.21421.88     Document Type: Review

References (64)

1. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents (Volume VII). Lyon: IARC Scientific Publications; 1997.
2. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48: 2485-2492.
3. Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer. 1999;85:1871-1884.
4. Bril V, Kojic J, Dhanani A. The long-term clinical outcome of myasthenia gravis in patients with thymoma. Neurology. 1998;51:1198-1200.
5. Muller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol 2000;12: 426-433.
6. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94:624-632.
7. Thomas CR Jr, Wright CD, Loehrer PJ Sr. Thymoma: state of the art. J Clin Oncol. 1999;17:2280-2289.
8. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma: a 13-year experience. Cancer. 1991;68:30-33.
9. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 1999;230:562-572.
10. Whooley BP, Urschel JD, Antkowiak JG, et al. A 25-year thymoma treatment review. J Exp Clin Cancer Res. 2000;19:3-5.
11. Kim ES, Putnam JB, Komaki R, et al. A phase II study of a multidisciplinary approach with induction chemotherapy (IC), followed by surgical resection (SR), radiation therapy (RT) and consolidation chemotherapy (CC) for unresectable malignant thymomas: final report. Proc Am Soc Clin Oncol. 2001;20:310a.
12. Lee WS, Heo DS, Bang YJ, et al. Prognostic factors of patients with thymoma. Korean J Intern Med. 1996;11:40-49.
13. Mehran R, Ghosh R, Maziak D, et al. Surgical treatment of thymoma. Can J Surg. 2002;45:25-30.
14. Kirschner PA. Reoperation on the thymus. A critique. Chest Surg Clin North Am. 2001;11:439-445.
15. Port JL, Ginsberg RJ. Surgery for thymoma. Chest Surg Clin North Am. 2001;11:421-437.
16. Mornex F, Resbeut M, Richaud P, et al. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys. 1995;32:651-659.
17. Resbeut M, Mornex F, Richaud P, et al. Radiotherapy of thymoma study of the literature apropos of a retrospective and multicenter series of 149 cases. Bull Cancer Radiother. 1995;82:9-19.
18. Bacha EA, Chapelier AR, Macchiarini P, et al. Surgery for invasive primary mediastinal tumors. Ann Thorac Surg. 1998;66:234-239.
19. Schmidt R, Monig SP, Selzner M, et al. Surgical therapy of malignant thymoma. J Cardiovasc Surg. 1997;38:317-322.
20. Yagi K, Hirata T, Fukuse T, et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg. 1996;61:521-524.
21. Graeber GM, Tamim W. Current status of the diagnosis and treatment of thymoma. Semin Thorac Cardiovasc Surg. 2000;12:268-277.
22. Regnard JF, Zinzindohoue F, Magdeleinat P, et al. Results of reresection for recurrent thymomas. Ann Thorac Surg. 1997;64:1593-1598.
23. Mineo TC, Biancari F. Reoperation for recurrent thymoma: experience in seven patients and review of the literature. Ann Chir Gynaecol. 1996;85:286-291.
24. Yim AP. Video-assisted thoracoscopic management of anterior mediastinal masses. Preliminary experience and results. Surg Endosc. 1995;9: 1184-1188.
25. Johnson SB, Eng TY, Giaccone G, et al. Thymoma: update for the new millennium (correction of millennium). Oncologist. 2001;6:239-246.
26. Dziuba SJ, Curran WJ Jr. The radiotherapeutic management of invasive thymomas. Chest Surg Clin North Am. 2001;11:457-466.
27. Zhang H, Lu N, Wang M, et al. Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases. Chin Med J (Engl). 1999;112:136-138.
28. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer. 2002;94:1405-1413.
29. Uematsu M, Yoshida H, Kondo M, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys. 1996;35:357-360.
30. Akaogi E, Ohara K, Mitsui K, et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol. 1996;63:17-22.
31. Bretti S, Loddo A, Berruti P, et al. Multimodal management of stage III-IV malignant thymoma: role of neoadjuvant approaches. Proc Am Soc Clin Oncol. 2002;21:333a.
32. Urgesi A, Monetti U, Rossi G, et al. Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol. 1992;24:221-225.
33. Bonomi PD, Finkelstein D, Aisner S, et al. EST 2582: Phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol. 1993; 16:342-345.
34. Highley MS, Underhill CR, Parnis FX, et al. Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol. 1999;17:2737-2744.
35. Tomiak EM, Evans WK. The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials. Crit Rev Oncol Hematol. 1993;15:113-124.
36. Latz D, Schraube P, Oppitz U, et al. Invasive thymoma: treatment with postoperative radiation therapy. Radiology. 1997;204:859-864.
37. Kosmidis PA, Iliopoulos E, Pentea S. Combination chemotherapy with cyclophosphamide, adriamycin, and vincristine in malignant thymoma and myasthenia gravis. Cancer. 1988;61:1736-1740.
38. Loehrer PJ Sr, Bonomi P, Goldman S, et al. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine. Chest. 1985;87:377-380.
39. Goldel N, Boning L, Fredrik A, et al. Chemotherapy of invasive thymoma. A retrospective study of 22 cases. Cancer. 1989;63:1493-1500.
40. Evans WK, Thompson DM, Simpson WJ, et al. Combination chemotherapy in invasive thymoma role of COPP. Cancer. 1980;46:1523-1527.
41. Loehrer PJ Sr, Kim K, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol. 1994;12:1164-1168.
42. Park HS, Shin DM, Lee JS, et al. Thymoma - a retrospective study of 87 cases. Cancer. 1994;73:2491-2498.
43. Oshita F, Kasai T, Kurata T, et al. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results. Jpn J Clin Oncol. 1995;25:208-212.
44. Bjerrum OW, Kiss K, Daugaard G. Combination chemotherapy with a five-drug regimen for invasive thymoma. Acta Oncol. 1996;35:71-73.
45. Giaccone G, Ardizzoni A, Kirkpatrick A, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 1996;14:814-820.
46. Loehrer PJ Sr, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer. 2001;91: 2010-2015.
47. Loehrer PJ Sr. Phase II study of carboplatin and paclitaxel in patients with advanced thymoma or thymic carcinoma (summary last modified 04/2001). Clinical trials (PDQ®). Available from URL: http://www.nci.nih.gov (accessed Sep 1, 2002).
48. Lara PN Jr, Bonomi PD, Faber LP. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide. Chest. 1996;110:1115-1117.
49. Weissberg D. Steroids for pulmonary metastases of thymoma. Ann Thorac Surg. 1998;65:1191-1200.
50. Termeer A, Visser FJ, Mravunac M. Regression of invasive thymoma following corticosteroid therapy. Neth J Med. 2001;58:181-184.
51. Loehrer PJ Sr, Chen M, Kim K, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15:3093-3099.
52. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991;68:706-713.
53. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg. 1993;106:543-549.
54. Venuta F, Rendina EA, Pescarmona EO, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg. 1997;64:1585-1591.
55. Berruti A, Borasio P, Gerbino A, et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer. 1999; 81:841-845.
56. Chahinian AP, Bhardwaj S, Meyer RJ, et al. Treatment of invasive or metastatic thymoma: report of eleven cases. Cancer. 1981;47:1752-1761.
57. Chahinian AP, Holland JF, Bhardwaj S. Chemotherapy for malignant thymoma. Ann Intern Med. 1983;99:736.
58. Daugaard G, Hansen HH, Rorth M. Combination chemotherapy for malignant thymoma. Ann Intern Med. 1983;99:189-190.
59. Froudarakis ME, Tiffet O, Fournel P, et al. Invasive thymoma: a clinical study of 23 cases. Respiration. 2001;68:376-381.
60. Palmieri G, Lastoria S, Montella L, et al. Phase II study results of somatostatin analogs and prednisolone in chemotherapy refractory thymoma patients. Proc Am Soc Clin Oncol. 1999;18:448a.
61. Gordon MS, Battiato LA, Gonin R, et al. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. J Immunother Emphasis Tumor Immunol. 1995;18:179-184.
62. Zoetmulder FA. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HIThoC) in patients with mesothelioma or pleural thymoma. Proc Am Soc Clin Oncol. 2001;20:274b.
63. Hanna N, Gharpure VS, Abonour R, et al. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Bone Marrow Transplant. 2001;28:435-438.
64. Henley JD, Koukoulis GK, Loehrer PJ Sr. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol. 2002;128:167-170.